logo-loader
RNS
MicroSalt PLC

Replacement - Issue of Equity, Warrants and TVR

RNS Number : 2218C
MicroSalt PLC
06 November 2026
 

The following amendment has been made to the ‘Issue of Equity and Total Voting Rights’ announcement released on 28 October 2026 at 7:00 under RNS No 7052A.

 

Fees due to Millwest to be settled by way of re-investment on the same terms as other investors pursuant to the Subscription, and therefore 400,000 warrants are also receivable. In addition, commission payable to certain other introducers agreed to be settled by the granting of 750,000 warrants with an exercise price of 20 pence per share.

 

Changes underlined. All other details remain unchanged. The full amended text is shown below.

 

MicroSalt Plc

("MicroSalt" or the "Company")

 

Issue of Equity, Granting of Warrants and Total Voting Rights

 

MicroSalt (AIM: SALT), a leading manufacturer of full-flavour natural salt with approximately 50% less sodium, announces it has issued 400,000 new ordinary shares to Millwest Investments Pty Ltd (“Millwest”) (the “Millwest Shares”) at a deemed price per share of 14 pence (the “Issue Price”), in lieu of services provided in connection with the Company’s recent equity subscription, announced on 24 September 2026 (the “Subscription”).

 

The Issue Price of 14 pence per share is the same price at which shares were issued pursuant to the Subscription.

 

This effective re-investment of the commission due to Millwest, was agreed to be on the same terms as other investors participating in the Subscription. Accordingly, the Company has also granted 400,000 warrants to Millwest, which conditionally entitle Millwest to subscribe for one new Ordinary Share per warrant issued, at an exercise price of 14 pence.

 

In addition, the Company has agreed that commission payable to certain other introducers (private individual shareholders) shall be settled by the granting of 750,000 warrants (in aggregate) with an exercise price of 20 pence per new Ordinary Share.

 

Admission and Total Voting Rights

 

Application has been made to London Stock Exchange plc for the admission to trading on AIM of the Millwest Shares (“Admission”). It is expected that Admission will become effective and dealings will commence at 8:00 a.m. on or around 29 October 2026.

 

Upon Admission, the Company's issued ordinary share capital will consist of 78,602,719 ordinary shares with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, from Admission the total number of ordinary shares and voting rights in the Company will be 78,602,719. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Millwest Shares will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the existing ordinary shares of the Company.

 

Warrants

 

A total of 12,157,609 warrants have therefore been granted by the Company pursuant to the Fundraising. The warrant certificates or CREST accounts (where warrants were requested in uncertificated form) are expected to be posted or credited, respectively, on 6 November 2026.

 

Capitalised terms used but not defined in this announcement have the meanings given to them in the Company's announcement released at 1:30 p.m. on 16 September 2026.

 

 

Enquiries:

 

MicroSalt plc

Via Gracechurch Group

Rick Guiney (CEO)

Gary Urmston, Interim CFO

 

 

 

Zeus (Nominated Adviser and Broker)

+44 (0)20 3829 5000

David Foreman / Ed Beddows (Investment Banking)

Nick Searle (Head of Equity Capital Markets)

 

 

 

Gracechurch Group (Financial PR)

+44 (0)20 4582 3500

Heather Armstrong, Alexis Gore, Rebecca Scott

 

 

 

About MicroSalt

 

MicroSalt is disrupting the global salt market with its patented, full-flavour, low-sodium salt designed for both food manufacturers and consumers. Using proprietary micron-sized particles, MicroSalt delivers the same salty taste as traditional salt with approximately 50% less sodium, offering a scalable solution to one of the world's most pressing health challenges.

 

Excess sodium consumption is a leading contributor to cardiovascular disease, the world's number one cause of death. The World Health Organisation targeted a 30% reduction in global sodium intake by 2025, a shift projected to save seven million lives by 2030. The economic case is equally compelling: in the UK alone, cardiovascular disease costs £19 billion annually, and reducing average daily salt intake by just one gram could save over 4,000 lives and £288 million each year.

 

For more information, please visit www.microsaltinc.com or follow on X @microSaltPLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBFBATMTBMBLF
NO INVESTMENT ADVICE

Proactive Investors Australia Pty Ltd ACN 132 787 654 (the Company, we or us) provides you with access to the content set out above, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) and this website (the Site) on the terms set out in this disclaimer, together with all other terms and conditions, disclaimers and other notices displayed elsewhere on this Site.

It is important for you to know that:

(a) none of the Content is, or is intended to be, general or personal advice

(b) the principal purpose of the Content is to provide factual information only and to comment on news;

(c) the Content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including in respect of any particular security, portfolio of securities, transaction or investment strategy, and must not be relied upon by you as such;

(d) in providing you with the Content, we have not considered your objectives, financial situation or needs; and

(e) you should make your own enquiries and obtain your own independent advice prior to making any financial decisions.

The Content contains data (including but not limited to prices, statistics and calculated information) obtained from a variety of third party sources (Third Party Data). The Company does not make any representation or warranty that any of the Content, including the Third Party Data, will be reliable, accurate or complete. The Company disclaims all responsibility and liability arising in any way from any errors or omissions in the Content, including the Third Party Data, including any loss you may incur in connection with any action or decision made by you in reliance upon the Content or Third Party Data.

In certain circumstances the Company, its related bodies corporate, or their affiliates, may have received, or be entitled to receive, financial or other consideration in connection with providing information about certain entities on the Site, which may include the above Content.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read